194 related articles for article (PubMed ID: 22178076)
1. IL-17A as a regulator of neutrophil survival in nasal polyp disease of patients with and without cystic fibrosis.
Derycke L; Zhang N; Holtappels G; Dutré T; Bachert C
J Cyst Fibros; 2012 May; 11(3):193-200. PubMed ID: 22178076
[TBL] [Abstract][Full Text] [Related]
2. Role of interleukin-17A in the eosinophil accumulation and mucosal remodeling in chronic rhinosinusitis with nasal polyps associated with asthma.
Saitoh T; Kusunoki T; Yao T; Kawano K; Kojima Y; Miyahara K; Onoda J; Yokoi H; Ikeda K
Int Arch Allergy Immunol; 2010; 151(1):8-16. PubMed ID: 19672092
[TBL] [Abstract][Full Text] [Related]
3. Degranulation of cystic fibrosis nasal polyp mast cells.
Henderson WR; Chi EY
J Pathol; 1992 Apr; 166(4):395-404. PubMed ID: 1517893
[TBL] [Abstract][Full Text] [Related]
4. CFTR and differentiation markers expression in non-CF and delta F 508 homozygous CF nasal epithelium.
Dupuit F; Kälin N; Brézillon S; Hinnrasky J; Tümmler B; Puchelle E
J Clin Invest; 1995 Sep; 96(3):1601-11. PubMed ID: 7544810
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase 2 and lipoxin A₄ in nasal polyps in cystic fibrosis.
Rozsasi A; Heinemann A; Keck T
Am J Rhinol Allergy; 2011; 25(6):e251-4. PubMed ID: 22185734
[TBL] [Abstract][Full Text] [Related]
6. Eosinophilic cationic protein as a marker of nasal inflammation in patients with cystic fibrosis.
Weber A; Kiefer J; Peters S; Schneider M; Bargon J; May A
Laryngoscope; 1999 Oct; 109(10):1696-702. PubMed ID: 10522945
[TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccharide induction of cyclooxygenase-2 in long-term nasal epithelial cultures in cystic fibrosis.
Rozsasi A; Keck T
Arch Otolaryngol Head Neck Surg; 2010 Apr; 136(4):335-9. PubMed ID: 20403848
[TBL] [Abstract][Full Text] [Related]
8. A Th17- and Th2-skewed cytokine profile in cystic fibrosis lungs represents a potential risk factor for Pseudomonas aeruginosa infection.
Tiringer K; Treis A; Fucik P; Gona M; Gruber S; Renner S; Dehlink E; Nachbaur E; Horak F; Jaksch P; Döring G; Crameri R; Jung A; Rochat MK; Hörmann M; Spittler A; Klepetko W; Akdis CA; Szépfalusi Z; Frischer T; Eiwegger T
Am J Respir Crit Care Med; 2013 Mar; 187(6):621-9. PubMed ID: 23306544
[TBL] [Abstract][Full Text] [Related]
9. The characterization of IL-17A expression in patients with chronic rhinosinusitis with nasal polyps.
Jiang XD; Li GY; Li L; Dong Z; Zhu DD
Am J Rhinol Allergy; 2011; 25(5):e171-5. PubMed ID: 22186234
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-17A expression in patients with chronic rhinosinusitis and its relationship with clinical features.
Hu XD; Bao YY; Zhou SH; Yao HT; Mao JY; Ji XX; Wu XH
J Int Med Res; 2013 Jun; 41(3):777-84. PubMed ID: 23613503
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of interleukin-9, interleukin-9 receptor, and the calcium-activated chloride channel hCLCA1 in the upper airways of patients with cystic fibrosis.
Hauber HP; Manoukian JJ; Nguyen LH; Sobol SE; Levitt RC; Holroyd KJ; McElvaney NG; Griffin S; Hamid Q
Laryngoscope; 2003 Jun; 113(6):1037-42. PubMed ID: 12782818
[TBL] [Abstract][Full Text] [Related]
12. Histology of nasal polyps of different etiology.
Sorensen H; Mygind N; Tygstrup I; Winge Flensborg E
Rhinology; 1977 Sep; 15(3):121-8. PubMed ID: 905718
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-8 production by cystic fibrosis nasal epithelial cells after tumor necrosis factor-alpha and respiratory syncytial virus stimulation.
Black HR; Yankaskas JR; Johnson LG; Noah TL
Am J Respir Cell Mol Biol; 1998 Aug; 19(2):210-5. PubMed ID: 9698592
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-17A-induced inflammation does not influence the development of nasal polyps in murine model.
Hong SL; Zhang YL; Kim SW; Kim DW; Cho SH; Chang YS; Lee CH; Rhee CS
Int Forum Allergy Rhinol; 2015 May; 5(5):363-70. PubMed ID: 25754984
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of chronic sinus diseases by measurement of inflammatory mediators.
Van Zele T; Claeys S; Gevaert P; Van Maele G; Holtappels G; Van Cauwenberge P; Bachert C
Allergy; 2006 Nov; 61(11):1280-9. PubMed ID: 17002703
[TBL] [Abstract][Full Text] [Related]
16. [Expression and cellular provenance of interleukin 17A in non-eosinophilic chronic rhinosinusitis with nasal polyps].
Chen XH; Chang LH; Huang JC; Li X; Lai XP; Wu XF; Huang ZZ; Wang ZY; Bao HW; Zhang GH
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Jun; 55(6):604-610. PubMed ID: 32610404
[No Abstract] [Full Text] [Related]
17. The ultrastructure of the nasal polyps in patients with and without cystic fibrosis.
Beju D; Meek WD; Kramer JC
J Submicrosc Cytol Pathol; 2004 Apr; 36(2):155-65. PubMed ID: 15554502
[TBL] [Abstract][Full Text] [Related]
18. The pathogenesis of nasal polyposis by immunoglobulin E and interleukin-5 is completed by transforming growth factor-beta1.
Hirschberg A; Jókúti A; Darvas Z; Almay K; Répássy G; Falus A
Laryngoscope; 2003 Jan; 113(1):120-4. PubMed ID: 12514394
[TBL] [Abstract][Full Text] [Related]
19. Contribution of the proinflammatory cytokine IL-18 in the formation of human nasal polyps.
Zhang G; Jing X; Wang X; Shi W; Sun P; Su C; Zhu M; Yang Z; Yao Z; Yang J
Anat Rec (Hoboken); 2011 Jun; 294(6):953-60. PubMed ID: 21538928
[TBL] [Abstract][Full Text] [Related]
20. Multiplex analyses of cytokine and chemokine release from the cultured fibroblast of nasal polyps: the effect of IL-17A.
Homma H; Kamiya K; Kusunoki T; Ikeda K
Acta Otolaryngol; 2013 Oct; 133(10):1065-72. PubMed ID: 24032570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
